Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boucher

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 11, 2013
[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]Jenneke Boot, Babette O Rump, Charles A B Boucher, et al.
AIDS (London, England)|December 17, 2009
Transmission networks of HIV-1 among men having sex with men in the NetherlandsDaniela Bezemer, Ard van Sighem, Vladimir V Lukashov, et al.
Retrovirology|January 10, 2015
Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacityMarieke Pingen, Annemarie M J Wensing, Katrien Fransen, et al.
The Journal of Infectious Diseases|July 25, 2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76VMonique Nijhuis, Annemarie M J Wensing, Wouter F W Bierman, et al.
Plos One|March 26, 2013
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling studyBrooke E Nichols, Charles A B Boucher, Janneke H van Dijk, et al.
Plos One|January 11, 2019
Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-menStephanie Popping, Sebastiaan J Hullegie, Anne Boerekamps, et al.
The Open Virology Journal|January 19, 2012
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008Frederika Dijkstra, Marcel Jonges, Ruud van Beek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
HIV-1 can persist in aged memory CD4+ T lymphocytes with minimal signs of evolution after 8.3 years of effective highly active antiretroviral therapyHans S L M Nottet, Sabine J van Dijk, Ewout B Fanoy, et al.
AIDS (London, England)|August 8, 2013
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling studyBrooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.
AIDS (London, England)|August 14, 2013
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical modelsDavid A M C van de Vijver, Brooke E Nichols, Ume L Abbas, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Nederlands Tijdschrift Voor Geneeskunde|July 11, 2013
[Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]Jenneke Boot, Babette O Rump, Charles A B Boucher, et al.
AIDS (London, England)|December 17, 2009
Transmission networks of HIV-1 among men having sex with men in the NetherlandsDaniela Bezemer, Ard van Sighem, Vladimir V Lukashov, et al.
Retrovirology|January 10, 2015
Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacityMarieke Pingen, Annemarie M J Wensing, Katrien Fransen, et al.
The Journal of Infectious Diseases|July 25, 2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76VMonique Nijhuis, Annemarie M J Wensing, Wouter F W Bierman, et al.
Plos One|March 26, 2013
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling studyBrooke E Nichols, Charles A B Boucher, Janneke H van Dijk, et al.
Plos One|January 11, 2019
Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-menStephanie Popping, Sebastiaan J Hullegie, Anne Boerekamps, et al.
The Open Virology Journal|January 19, 2012
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008Frederika Dijkstra, Marcel Jonges, Ruud van Beek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 14, 2009
HIV-1 can persist in aged memory CD4+ T lymphocytes with minimal signs of evolution after 8.3 years of effective highly active antiretroviral therapyHans S L M Nottet, Sabine J van Dijk, Ewout B Fanoy, et al.
AIDS (London, England)|August 8, 2013
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling studyBrooke E Nichols, Kim C E Sigaloff, Cissy Kityo, et al.
AIDS (London, England)|August 14, 2013
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical modelsDavid A M C van de Vijver, Brooke E Nichols, Ume L Abbas, et al.
Pageof 18